Another example of an unclassified subset is the CD3− CD68+ CD4+ GrB+ cell population, which is higher in cHL patients who respond to anti-PD-L1 therapy and in healthy donors than in newly diagnosed patients [29]. This evidence concerns the gene CD68 and classic Hodgkin lymphoma.